Federal health officials this week proposed sweeping reforms to speed up drug approvals across Medicare , Medicaid and other government-linked health plans. Long delays tied to insurance approval have become one of the biggest barriers between patients and prescribed treatment, drawing growing scrutiny from doctors and policymakers. Millions of patients, doctors and insurers would be affected by tighter deadlines, new transparency requirements and a shift toward electronic drug authorization